Budipine
NERVOUS SYSTEM
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Budipine is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including KCNH2 and GRIN2D|GRIN3B|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN3A.
- Molecular targets: KCNH2 and GRIN2D|GRIN3B|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN3A (2 listed in DrugCentral).
- ATC code: N04BX03 (Other dopaminergic agents).
- Molecular formula: C21H27N; molecular weight 293.45 g/mol.
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | KCNH2 | unknown | IC50 6.07 |
| Glutamate [NMDA] receptor | GRIN2D|GRIN3B|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN3A | unknown | Ki 4.93 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N04BX03 | NERVOUS SYSTEM › ANTI-PARKINSON DRUGS › DOPAMINERGIC AGENTS › Other dopaminergic agents |
Chemical structure
| Molecular formula | C21H27N |
|---|---|
| Molecular weight | 293.45 g/mol |
| CAS number | 57982-78-2 |
| InChIKey | QIHLUZAFSSMXHQ-UHFFFAOYSA-N |
| PubChem CID | 68778 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Budipine work?
Its molecular targets in DrugCentral include KCNH2 and GRIN2D|GRIN3B|GRIN1|GRIN2A|GRIN2B|GRIN2C|GRIN3A.
What is the chemical formula of Budipine?
Budipine has the molecular formula C21H27N and a molecular weight of 293.45 g/mol.
Browse: all drugs starting with B · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 420 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL334491 — compound record and bioactivity
- PubChem CID 68778 — chemical identifiers
- DrugBank DB13502 — drug record
- FDA UNII L9026OPI2Z — substance identity
- UniProt Q12809 (KCNH2) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.